Home Tags Telitacicept

Tag: Telitacicept

RC118 Targeting Claudin 18.2 ADC Receives Two Orphan Drug Designations

RC118, an antibody-drug conjugates or ADC being developed by RemeGen, a commercial-stage biotechnology company based in Yantai, China, has been granted two orphan drug...